White Paper Icon

Global Evidence Generation Checklist

Planning an integrated evidence generation strategy early in your product development life cycle helps maximize your value proposition and strengthen the position of your product for approval and marketing.

UBC’s Global Evidence Generation Checklist helps you identify the key points to meet the needs of patients, providers, regulators, and payers. Kickstart internal conversations by downloading the checklist using the form to the right.

 

UBC Pinwheel logo

Download The Checklist

Related Resources
For evidence generation teams working to JCA timelines: this white paper sets out the expert-guided model for AI-assisted literature review, the eight stages where technology accelerates and experts decide, the governance that keeps reviews auditable, and where seven HTA bodies currently stand on AI.
Explore how lifecycle HTA evaluates health technologies as evidence matures, and how real-world evidence, patient-reported outcomes, and equity move from supporting detail to core inputs in value and reassessment decisions.
For PV leaders navigating AI adoption: this white paper maps real-world use cases across case processing, safety reporting, and regulatory intelligence, alongside the security, validation, and build-versus-buy decisions that come with them. Plus the centaur model, where human oversight stays non-negotiable.
UBC logo white

Thank You for Connecting with UBC

.

 

What You Can Expect Next

.

UBC logo white

Get Ready to Change Your Business

.

Service Request

Bekki Bracken Brown Headshot

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.